您的位置: 首页 > 农业专利 > 详情页

Composition for treating lung cancer, particularly of non-small lung cancers (NSCLC)
专利权人:
CureVac GmbH
发明人:
Hoerr, Ingmar,Probst, Jochen,Barner, Marijke,Lander, Thomas
申请号:
AU2008309930
公开号:
AU2008309930B2
申请日:
2008.10.08
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
The present invention relates to an active (immunostimulatory) compositioncomprising at least one RNA, preferably a mRNA, encoding at least two (preferablydifferent) antigens capable of eliciting an (adaptive) immune response in amammal. The invention furthermore relates to a vaccine comprising said active(immunostimulatory) composition, and to the use of said active (immunostimulatory)composition (for the preparation of a vaccine) and/or of the vaccine for elicitingan (adaptive) immune response for the treatment of lung cancer, particularlyof non-small cell lung cancers (NSCLC), preferably selected from the three mainsub-types squamous cell lung carcinoma, adenocarcinoma and large cell lungcarcinoma, or of disorders related thereto. Finally, the invention relatesto kits, particularly to kits of parts, containing the active (immunostimulatory)composition and/or the vaccine.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充